ZEB1 and breast carcinoma: The dynamic EMT and MET was also observed in parental and HCC38 cells delineated by EpCAM profiling [26], in Zeb1 driving CD44Low to CD44High cellular plasticity [58] and in mammary carcinoma mouse MyPT models delineated by E-cadherin profiling [30].